nimodipine has been researched along with Addiction, Opioid in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosse, RB | 1 |
| Alim, TN | 1 |
| Fay-McCarthy, M | 1 |
| Collins, JP | 1 |
| Vocci, FJ | 1 |
| Lindquist, T | 1 |
| Jentgen, C | 1 |
| Hess, AL | 1 |
| Deutsch, SI | 1 |
1 trial available for nimodipine and Addiction, Opioid
| Article | Year |
|---|---|
Nimodipine pharmacotherapeutic adjuvant therapy for inpatient treatment of cocaine dependence.
Topics: Calcium Channel Blockers; Chemotherapy, Adjuvant; Crack Cocaine; Double-Blind Method; Humans; Inpati | 1994 |